These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6259606)

  • 1. [Cefotaxime in the treatment of severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Clumeck N; Van Laethem Y; Vanhoof R; Jaspar N; George G; Rapin M; Butzler JP
    Nouv Presse Med; 1981 Feb; 10(8):622-4. PubMed ID: 6259606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Dureux JB; Canton P; Roche G; Weber M; Gérard A
    Nouv Presse Med; 1981 Feb; 10(8):601-6. PubMed ID: 6259602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefotaxime therapy of serious infections with multiresistant gram-negative bacilli.
    Clumeck N; van Laethem Y; Vanhoof R; George C; Rapin M; Butzler JP
    Scand J Infect Dis; 1982; 14(1):57-60. PubMed ID: 6280269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experience of cefotaxime (author's transl)].
    Portier H; Carbon C; Boussougant Y; Destaing F
    Nouv Presse Med; 1981 Feb; 10(8):607-11. PubMed ID: 6259603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cefotaxime in bronchopulmonary infections (author's transl)].
    Kermarec J; Sauvaget J
    Nouv Presse Med; 1981 Feb; 10(8):650-3. PubMed ID: 6259612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of cefotaxime at various dosage levels in urinary tract infections (author's transl)].
    Guibert J; Acar JF; Justin C; Kitzis MD
    Nouv Presse Med; 1981 Feb; 10(8):625-7. PubMed ID: 6259607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of cefotaxime against infections (author's transl)].
    Lepeu G; Bertrand A; Armengaud M; Aubertin J
    Nouv Presse Med; 1981 Feb; 10(8):594-7. PubMed ID: 6259600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cefotaxime in the treatment of purulent meningitis in children (author's transl)].
    Borderon JC; Despert F; Santini JJ; Laugier J; Grenier B; Boulard P
    Nouv Presse Med; 1981 Feb; 10(8):634-8. PubMed ID: 6259609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Gram-negative septicaemia with cefotaxime: 16 cases (author's transl)].
    Goulon M; Gajdos P; Pilliot J
    Nouv Presse Med; 1981 Feb; 10(8):613-6. PubMed ID: 6259604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cefotaxime and Gram-negative infections in children. Effectiveness and tolerance (author's transl)].
    Aufrant C; Lambert-Zechovsky N; Aujard Y; Bingen E; Blum C; Beaufils F; Mathieu H
    Nouv Presse Med; 1981 Feb; 10(8):639-46. PubMed ID: 6259610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Place of cefotaxime in the treatment of septicaemias due to enterobacteriaceae (author's transl)].
    Bastin R; Frottier J; Vilde JL; Bure A
    Nouv Presse Med; 1981 Feb; 10(8):598-600. PubMed ID: 6259601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cefotaxime in digestive tract infections (author's transl)].
    Paris J; Paris JC; Gérard A
    Nouv Presse Med; 1981 Feb; 10(8):647-9. PubMed ID: 6259611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of tobramycin in severe infections (author's transl)].
    Babinet P; Bricaire F; Tancrede C; Goulon M
    Sem Hop; 1978 Oct 18-25; 54(33-36):1049-54. PubMed ID: 220716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cefotaxime in childhood infections (author's transl)].
    Garnier JM; Giraud F
    Nouv Presse Med; 1981 Feb; 10(8):629-33. PubMed ID: 6259608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cefotaxime treatment of 25 cases of severe enterobacteriaceae infections in an intensive care unit (author's transl)].
    Motin J; Bouletreau P; Auboyer C; Bui-Xuan B; Flandrois JP; Reverdy ME
    Nouv Presse Med; 1981 Feb; 10(8):617-21. PubMed ID: 6259605
    [No Abstract]   [Full Text] [Related]  

  • 17. Ceftriaxone in the treatment of serious infections, particularly after surgery.
    Scully BE; Neu HC
    Am J Surg; 1984 Oct; 148(4A):35-40. PubMed ID: 6091479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the efficacy of cefotaxime alone and the combination cefazolin-tobramycin in the treatment of enterobacterial septicemia].
    Arich C; Gouby A; Bengler C; Ardilouze JL; Dubois A; Joubert P; Hansel S; Janbon C; Fabre S
    Pathol Biol (Paris); 1987 May; 35(5):613-5. PubMed ID: 3302868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical trial of a new broad-spectrum cephalosporin: HR 756 (cefotaxime)].
    Poletti T; Bertola D; Pellerito R; Soragna A
    Minerva Med; 1980 Jul; 71(27):1935-43. PubMed ID: 6248823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.